President Donald Trump on Friday will unveil a sweeping strategy for lowering drug prices that aims to reshape Medicare, boost competition and pressure foreign governments that the White House believes are “freeloading” off of the U.S. pharmaceutical industry, two senior administration officials said Thursday night.
The long-awaited plan represents a mix of existing policies laid out in the Trump administration’s 2019 budget blueprint as well as some new ideas designed to drive down drug prices and lower patients’ out-of-pocket costs.
via Politico.
Related Reading:
Options for Implementing Medicare Drug Negotiation.
- At a time when policymakers are seeking ways to lower the federal deficit and overall health care spending, proposals that reduce Medicare prescription drug costs cannot be overlooked.
- Allowing the federal government to negotiate for lower Medicare drug prices and restoring discounts for low-income beneficiaries make sense because these proposals save money without shifting costs to beneficiaries and have broad public support.
